Skip to content

Predictivity of Hemogasanalysis and Lung UltraSound in Determining COVID-19 Severity

Predictivity of hEmoGasAnalysis Associated to Bedside Lung UltraSound in Determining COVID-19 Severity in the Emergency Departement

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04689672
Acronym
COVID-PEGALUS
Enrollment
600
Registered
2020-12-30
Start date
2020-12-16
Completion date
2021-05-10
Last updated
2020-12-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19

Brief summary

This retrospective-prospective longitudinal observational study was designed to evaluate the role of bedside lung ultrasound per se and in association with hemogasanalysis parameters in predicting the severity of COVID-19 patients in the Emergency Departement (ED). Retrospective data regarding patients who presented at the ED of IRCCS San Raffaele Hospital from 10/11/2020, together with those acquired by the observation of patients who will access to the ED until 10/05/2021 will be collected, configuring a total enrollment period of 6 months. Clinical informations about patients' medical history will be recorded, with particular focus on the type and date of onset of the symptoms. The diagnostic and therapeutic strategy will be chosen according to the current standard of care. Results of bedside lung ultrasound, together with vital parameters, blood gas analysis, laboratory and other findings will be recorded. The primary outcome will be defined as patients' outcome at time of discharge from the ED, in terms of intensity of required care (home discharge, low or high-intensity care hospitalization, death). Secondary outcomes will be patients' prognosis 30 days after access to ED and the required intensity of care (eg need for non-invasive ventilation, oro-tracheal intubation).The follow-up 30 days after access to the ED will be evaluated by telephone survey or by consulting medical records.

Interventions

DIAGNOSTIC_TESTLung ultrasound

Bedside lung ultrasound

Sponsors

IRCCS San Raffaele
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* SARS - CoV 2 infection confirmed by positive RT-PCR on nasopharyngeal swab

Exclusion criteria

* impossibility to perform lung ultrasound due to technical limitations.

Design outcomes

Primary

MeasureTime frameDescription
Patients' short-term outcomeUp to 7 daysPatients' outcome at time of discharge from the Emergency Departement, expressed in terms of intensity of required care (home discharge, low or high-intensity care hospitalization, death).

Secondary

MeasureTime frameDescription
Patients' long-term outcome30 days after access to the Emergency DepartementPatients' outcome 30 days after access to the Emergency Departement, expressed in terms of intensity of required care (home discharge, low or high-intensity care hospitalization, death).
Intensity of careUp to 7 daysRequired intensity of care during the observational period in the Emergency Departement (eg need for non-invasive ventilation, oro-tracheal intubation).

Countries

Italy

Contacts

Primary ContactPaola AM Maffi, MD, PhD
maffi.paola@hsr.it+390226432575

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026